Indomethacin therapy in premature infants of advanced postnatal age.

B. Achanti, S. Pyati, T. F. Yeh

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


Indomethacin (0.3 mg/kg every eight hours IV for three doses) was administered to eight infants whose postnatal ages were eight weeks or greater and who developed patent ductus arteriosus either in the late postnatal life or in the early neonatal period but persisted. In spite of maintenance of appropriate plasma indomethacin levels, none of the infants responded with ductus closure. The present study suggests that a distinct group of infants may exist whose ductus arteriosus is prostaglandin independent and the patency of the ductus may persist.

Original languageEnglish
Pages (from-to)235-237
Number of pages3
JournalJournal of perinatology : official journal of the California Perinatal Association
Issue number3
Publication statusPublished - Jun 1 1987
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology


Dive into the research topics of 'Indomethacin therapy in premature infants of advanced postnatal age.'. Together they form a unique fingerprint.

Cite this